[Antibacterial efficacy of a new chemotherapeutic agent in acute infections of the upper respiratory tract in childhood. Controlled clinical trial of xibornol and josamycin].
D000208:Acute Disease; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001892:Camphanes / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007223:Infant; D007933:Leucomycins / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D013997:Time Factors
D000890:Anti-Infective Agents; D001892:Camphanes; D007933:Leucomycins; C003773:xibornol
Efficacia antibatterica di un nuovo chemioterapico nelle infezioni acute delle prime vie aeree in età pediatrica. Studio clinico controllato tra Xibornolo e Josamicina.